Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Wakame (Undaria pinnatifida) is an edible seaweed commonly consumed in East Asian cuisine. Its purported use in supporting or treating osteoporosis is primarily based on its nutrient content, particularly calcium, magnesium, and fucoidan—a sulfated polysaccharide unique to brown seaweeds. Some in vitro and animal studies suggest that fucoidan and other bioactive compounds in wakame may have a positive effect on bone health by promoting osteoblast activity and inhibiting osteoclast differentiation, thereby potentially reducing bone loss. For example, a study in rats published in Phytotherapy Research (2009) found that fucoidan supplementation improved bone mineral density in ovariectomized rats, a common model for postmenopausal osteoporosis.

However, direct evidence in humans is very limited. While wakame is a good dietary source of calcium, the bioavailability of its minerals can be affected by its high fiber content and presence of alginates, which may inhibit absorption. Additionally, there are no large-scale clinical trials demonstrating a clear benefit of wakame consumption for osteoporosis prevention or treatment in humans. The use of wakame for osteoporosis is not part of traditional herbal medicine systems, but the scientific interest stems from its nutrient profile and preclinical findings. Overall, while there is emerging scientific rationale, the current level of evidence is low and does not warrant its recommendation as a primary strategy for osteoporosis management.

More about Wakame
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by Wakame

Products containing Wakame